BioSpace News Archive

The Liver Meeting 2019, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 8-12 in Boston, MA.

Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its third quarter 2019 financial results after the close of market on Thursday, November 14, 2019.

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its technology partner, Mannin, has received a $7.5M grant from the German state of Saxony

pCare™ has entered into a new partnership with Redox, a leading cloud interoperability platform that standardizes data exchange across the technology solutions used by healthcare organizations

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, today announced it will host a cocktail reception featuring a panel discussion of Delmar’s glioblastoma multiforme (GBM) trial status with highly recognized thought leaders in GBM during the 2019 Society for NeuroOncology Annual Meeting in Phoenix, Ariz.

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at two investor conferences in November:

Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to present at the 28th Annual Healthcare Conference on Tuesday, November 12, 2019, at 4:10 p.m. MST

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, November 12, 2019 to report its third quarter 2019 financial results and provide a corporate update.

MindBytes BVBA and its subsidiary, MindLab Interactive AI Inc., (“MindBytes”) today announced that researchers from the Manchester Centre for Health Economics, at The University of Manchester recently published a manuscript in the journal The Patient, comparing an evidence-based interactive educational tool developed by MindBytes against plain-text educational materials as part of a preference study in rheumatoid arthritis (the “Study”).

New Quaternary Solvent Manager Enables Polymer Chemists to Perform Analyses on a Single System that Conventionally Required Multiple Instruments and Retrofitting